WORLDTECH NEWS Global technology intelligence.Contact
← Back to WORLDTECH

Heading Home: NASA’s SpaceX Crew-12 Concludes Station Science Mission

Meet NASA Astronaut Mike Fincke, Crew-11 Pilot (jsc2025m000138).webm
Reference image.Photo: NASA Johnson Space Center / Wikimedia Commons · Public domain
Full creditFile:Meet NASA Astronaut Mike Fincke, Crew-11 Pilot (jsc2025m000138).webm / NASA Johnson Space Center / This image or video was catalogued by Lyndon B. Johnson Space Center of the United States National Aeronautics and Space Administration (NASA) under Photo ID: jsc2025m000138_Crew11FinckeProfile_4K . / Wikimedia Commons / Public Domain / https://commons.wikimedia.org/wiki/File:Meet_NASA_Astronaut_Mike_Fincke,_Crew-11_Pilot_(jsc2025m000138).webmSource page

What happened

Heading Home: NASA’s SpaceX Crew-12 Concludes Station Science Mission, NASA News Releases announced. NASA’s SpaceX Crew-12 mission is ending, with the crew scheduled to return in early October. 5 Min Read Heading Home: NASA’s SpaceX Crew-12 Concludes Station Science Mission NASA’s SpaceX Crew-12 mission is ending, with the crew scheduled to return in early October. NASA is a space exploration and public company founded in 1958. SpaceX is a space company based in Hawthorne, and its products and services include Dragon.

Here’s a look back at some of their accomplishments: Orbital transit NASA/ESA The crew members look out the window of a Dragon spacecraft during their journey to the space station, a destination that offers a unique vantage point to observe both Earth and the cosmos. Research in microgravity allows the scientific community to experiment through a new perspective, from changes in how cells behave to how materials take shape, space offers new paths to scientific discovery.

Crystalline clues NASA/Jessica Meir Hathaway floats alongside hardware used for crystal growth experiments aboard the orbiting laboratory. Microgravity reveals new details about crystal structures, helping researchers improve the quality and stability of pharmaceuticals.

Sources & evidence